Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Structural insights into the promutagenic bypass of the major cisplatin-induced DNA lesion.

Authors: Ouzon-Shubeita, Hala; Vilas, Caroline K; Lee, Seongmin

Published In Biochem J, (2020 03 13)

Abstract: The cisplatin-1,2-d(GpG) (Pt-GG) intrastrand cross-link is the predominant DNA lesion generated by cisplatin. Cisplatin has been shown to predominantly induce G to T mutations and Pt-GG permits significant misincorporation of dATP by human DNA polymerase β (polβ). In agreement, polβ overexpression, which is frequently observed in cancer cells, is linked to cisplatin resistance and a mutator phenotype. However, the structural basis for the misincorporation of dATP opposite Pt-GG is unknown. Here, we report the first structures of a DNA polymerase inaccurately bypassing Pt-GG. We solved two structures of polβ misincorporating dATP opposite the 5'-dG of Pt-GG in the presence of Mg2+ or Mn2+. The Mg2+-bound structure exhibits a sub-optimal conformation for catalysis, while the Mn2+-bound structure is in a catalytically more favorable semi-closed conformation. In both structures, dATP does not form a coplanar base pairing with Pt-GG. In the polβ active site, the syn-dATP opposite Pt-GG appears to be stabilized by protein templating and pi stacking interactions, which resembles the polβ-mediated dATP incorporation opposite an abasic site. Overall, our results suggest that the templating Pt-GG in the polβ active site behaves like an abasic site, promoting the insertion of dATP in a non-instructional manner.

PubMed ID: 32039434 Exiting the NIEHS site

MeSH Terms: Antineoplastic Agents/chemistry*; Antineoplastic Agents/toxicity; Cisplatin/chemistry*; Cisplatin/toxicity; Crystallography, X-Ray/methods; DNA Damage/drug effects; DNA Damage/physiology*; DNA-Directed DNA Polymerase/chemistry*; DNA-Directed DNA Polymerase/genetics*; Humans; Mutagenesis/drug effects; Mutagenesis/physiology*; Protein Structure, Secondary

to Top